Literature DB >> 28882835

Haplo, we have a problem.

Christopher S Hourigan1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28882835      PMCID： PMC5606009          DOI： 10.1182/blood-2017-07-795062

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transplantation.

Authors:  Marcos de Lima; David L Porter; Minoo Battiwalla; Michael R Bishop; Sergio A Giralt; Nancy M Hardy; Nicolaus Kröger; Alan S Wayne; Christoph Schmid
Journal:  Biol Blood Marrow Transplant       Date:  2013-09-07       Impact factor: 5.742

2.  A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT.

Authors:  Müberra Ahci; Cristina Toffalori; Evelien Bouwmans; Pietro Crivello; Chiara Brambati; Cinzia Pultrone; Karin Stempelmann; Douglas Bost; Benedetta Mazzi; Dietrich W Beelen; Fabio Ciceri; Wietse Mulder; Katharina Fleischhauer; Luca Vago
Journal:  Blood       Date:  2017-06-27       Impact factor: 22.113

Review 3.  Measurable residual disease testing in acute myeloid leukaemia.

Authors:  C S Hourigan; R P Gale; N J Gormley; G J Ossenkoppele; R B Walter
Journal:  Leukemia       Date:  2017-04-07       Impact factor: 11.528

4.  Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.

Authors:  Sergio A Giralt; Charles F LeMaistre; Navneet S Majhail; Stephanie H Farnia; Paul A Carpenter; Richard E Champlin; Stephen Crawford; David I Marks; James L Omel; Paul J Orchard; Jeanne Palmer; Wael Saber; Bipin N Savani; Paul A Veys; Christopher N Bredeson
Journal:  Biol Blood Marrow Transplant       Date:  2015-08-07       Impact factor: 5.742

5.  HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.

Authors:  Loren Gragert; Mary Eapen; Eric Williams; John Freeman; Stephen Spellman; Robert Baitty; Robert Hartzman; J Douglas Rizzo; Mary Horowitz; Dennis Confer; Martin Maiers
Journal:  N Engl J Med       Date:  2014-07-24       Impact factor: 91.245

6.  Loss of mismatched HLA in leukemia after stem-cell transplantation.

Authors:  Luca Vago; Serena Kimi Perna; Monica Zanussi; Benedetta Mazzi; Cristina Barlassina; Maria Teresa Lupo Stanghellini; Nicola Flavio Perrelli; Cristian Cosentino; Federica Torri; Andrea Angius; Barbara Forno; Monica Casucci; Massimo Bernardi; Jacopo Peccatori; Consuelo Corti; Attilio Bondanza; Maurizio Ferrari; Silvano Rossini; Maria Grazia Roncarolo; Claudio Bordignon; Chiara Bonini; Fabio Ciceri; Katharina Fleischhauer
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

Review 7.  Modern approaches to HLA-haploidentical blood or marrow transplantation.

Authors:  Christopher G Kanakry; Ephraim J Fuchs; Leo Luznik
Journal:  Nat Rev Clin Oncol       Date:  2015-08-25       Impact factor: 66.675

Review 8.  Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis.

Authors:  Sarah A Buckley; Brent L Wood; Megan Othus; Christopher S Hourigan; Celalettin Ustun; Michael A Linden; Todd E DeFor; Michele Malagola; Chloe Anthias; Veronika Valkova; Christopher G Kanakry; Bernd Gruhn; Francesco Buccisano; Beth Devine; Roland B Walter
Journal:  Haematologica       Date:  2017-01-25       Impact factor: 9.941

9.  Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.

Authors:  J R Passweg; H Baldomero; P Bader; C Bonini; R F Duarte; C Dufour; A Gennery; N Kröger; J Kuball; F Lanza; S Montoto; A Nagler; J A Snowden; J Styczynski; M Mohty
Journal:  Bone Marrow Transplant       Date:  2017-03-13       Impact factor: 5.483
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.